Cargando…

Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB

Natural products are widely used as source for drugs development. An interesting example is represented by natural drugs developed against human topoisomerase IB, a ubiquitous enzyme involved in many cellular processes where several topological problems occur due the formation of supercoiled DNA. Hu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottaviani, Alessio, Iacovelli, Federico, Fiorani, Paola, Desideri, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073192/ https://www.ncbi.nlm.nih.gov/pubmed/33923641 http://dx.doi.org/10.3390/ijms22084138

Ejemplares similares

In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB
por: Soren, Bini Chhetri, et al.
Publicado: (2021)

Topoisomerase IB: a relaxing enzyme for stressed DNA
por: Soren, Bini Chhetri, et al.
Publicado: (2020)

Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B
por: Ottaviani, Alessio, et al.
Publicado: (2022)

Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico
por: Tesauro, Cinzia, et al.
Publicado: (2013)

Replacement of the Human Topoisomerase Linker Domain with the Plasmodial Counterpart Renders the Enzyme Camptothecin Resistant
por: Arnò, Barbara, et al.
Publicado: (2013)

From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge Dendrilla antarctica
por: Ottaviani, Alessio, et al.
Publicado: (2022)

The open state of human topoisomerase I as probed by molecular dynamics simulation
por: Chillemi, Giovanni, et al.
Publicado: (2007)

Peptide Inhibition of Topoisomerase IB from Plasmodium falciparum
por: Roy, Amit, et al.
Publicado: (2011)

The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant
por: Fiorani, Paola, et al.
Publicado: (2006)

A small organic compound enhances the religation reaction of human topoisomerase I and identifies crucial elements for the religation mechanism
por: Arnò, Barbara, et al.
Publicado: (2013)

A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance
por: Losasso, Carmen, et al.
Publicado: (2008)

Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study
por: Chillemi, Giovanni, et al.
Publicado: (2005)

Role of the protein in the DNA sequence specificity of the cleavage site stabilized by the camptothecin topoisomerase IB inhibitor: a metadynamics study
por: Coletta, Andrea, et al.
Publicado: (2013)

Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations
por: Chillemi, Giovanni, et al.
Publicado: (2008)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism
por: Sengupta, Souvik, et al.
Publicado: (2011)

Engineering a responsive DNA triple helix into an octahedral DNA nanostructure for a reversible opening/closing switching mechanism: a computational and experimental integrated study
por: Ottaviani, Alessio, et al.
Publicado: (2018)

Development of Derivatives of 3, 3′-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons
por: Roy, Amit, et al.
Publicado: (2011)

Role of Flexibility in Protein-DNA-Drug Recognition: The Case of Asp677Gly-Val703Ile Topoisomerase Mutant Hypersensitive to Camptothecin
por: D'Annessa, Ilda, et al.
Publicado: (2012)

Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant
por: Fiorani, Paola, et al.
Publicado: (2009)

Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers
por: Tesauro, Cinzia, et al.
Publicado: (2014)

Microheterogeneity of Topoisomerase IA/IB and Their DNA-Bound States
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2019)

The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis
por: Baechler, S. A., et al.
Publicado: (2019)

The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
por: Yu, Qian, et al.
Publicado: (2019)

topIb, a phylogenetic hallmark gene of Thaumarchaeota encodes a functional eukaryote-like topoisomerase IB
por: Dahmane, Narimane, et al.
Publicado: (2016)

Functional Expression of a DNA-Topoisomerase IB from Cryptosporidium parvum
por: Ordóñez, César, et al.
Publicado: (2009)

Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
por: Pérez-Pertejo, Yolanda, et al.
Publicado: (2019)

Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC
por: Zoppoli, Gabriele, et al.
Publicado: (2011)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy
por: Vindigni, Giulia, et al.
Publicado: (2021)

Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I – DNA Complex
por: Mancini, Giordano, et al.
Publicado: (2010)

Identification and Characterization of the Regions Involved in the Nuclear Translocation of the Heterodimeric Leishmanial DNA Topoisomerase IB
por: Prada, Christopher F., et al.
Publicado: (2013)

Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
por: Yakkala, Prasanna Anjaneyulu, et al.
Publicado: (2023)

Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends
por: Scaria, Benjamin, et al.
Publicado: (2020)

Analysis of naphthoquinone derivatives as topoisomerase I inhibitors using fragment based QSAR
por: Virupaksha, Bastikar, et al.
Publicado: (2013)

Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
por: Dey, Isha, et al.
Publicado: (2016)

Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors
por: Liu, Jin-Chuan, et al.
Publicado: (2022)

Phytobioactive compounds as therapeutic agents for human diseases: A review
por: Riaz, Muhammad, et al.
Publicado: (2023)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing
por: Raniolo, Sofia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m41c2e4e17ti2mtu3l6t8up1t8